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(LDH release) and apoptotic (TUNEL) cell death, sGAG release (DMMB),
tissue integration (histology, SEM, TEM), and matrix gene expression
(qPCR).
Results: Wounding resulted in a signiﬁcant increase in LDH release
compared to unwounded cartilage (p< 0.001). The pan-caspase inhibitor,
Z-VAD-FMK signiﬁcantly reduced LDH release (p< 0.001) and apoptosis
occurring at the wound edge. Necrostatin-1 also reduced LDH release
(p< 0.01). Both inhibitors reduced the level of sGAG lost into the me-
dia that resulted from wounding the cartilage. Toluidine blue staining,
SEM and TEM of cartilage revealed signiﬁcant integration of the wound
edges in composites treated with Z-VAD-FMK. Necrostatin-1 improved
integration but to a lesser extent. Quantitative PCR analysis revealed
an increase in the expression of type II collagen mRNA in Z-VAD-FMK
treated disc/ring composites.
Conclusions: This study shows that treatment of articular cartilage with
cell death inhibitors prior to and during wound repair increases the
number of viable cells at the wound edge, prevents matrix loss and results
in a signiﬁcant improvement in cartilage-cartilage integration.
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Purpose: Under appropriate culture conditions, mesenchymal stem cells
(MSCs) can rapidly differentiate into chondrocyte-like cells and elaborate
an extracellular matrix that is biochemically similar to that of hyaline
cartilage. This differentiation potential has broad implications for the use
of these cells in cartilage tissue engineering. Immunohistochemical and
biochemical analyses show that, e.g., cartilage ECM molecules become
detectable within the ﬁrst week of the differentiation process. These
phenotypic changes presuppose a radical reprogramming of the gene
expression proﬁles and physiology of MSCs. To support our studies
of chondrogenic MSC differentiation, we have used gene expression
microarrays to create a comprehensive database documenting the se-
quence and extent of these changes.
Methods: Five human MSC (hMSC) preparations, derived from bone
marrow aspirates obtained from the MSC Core Facility at CWRU under
an IRB-approved protocol, were used in these experiments. The cells
were expanded in medium containing serum and FGF-2. After 1 passage,
the cells were moved to aggregate culture at 2.5×105 cells/aggregate in
chondrogenic medium to induce differentiation.
At days 0, 1, 3, 5, and 7, total RNA was extracted from 20 aggre-
gates/timepoint/donor. 5−8mg of spin column-cleanedtotal RNA were
reverse-transcribed. The 3 best quality cDNA preparations were selected
for microarray analysis at the CWRU Gene Expression Array Core Fa-
cility, using Affymetrix HU133-A2 human microarrays (~22,277 full-length
genes and ESTs). Spiked bacterial IVT transcripts served as hybridization
controls.
Raw microarray data were normalized and analyzed using the Affymetrix
Microarray suite and Agilent GeneSpring. Binary comparisons were made
between samples from each time-point. A master list of differentially
expressed transcripts, which were consistently called as either increased
or decreased in all 3 replicates, and had an average absolute fold change
2.0 was deﬁned. These ﬁltered data were then further analyzed using
the Agilent GeneSpring and Ariadne Pathway Studio software packages
for clustering and regulation patterns and for assignment to speciﬁc
cellular pathways.
Results: All 15 arrays passed internal quality control. After ﬁltering data
for credible changes in gene expression, we found a high-value population
of 3,285 differentially expressed genes. Most of these changes occurred
between day 0 and day 1 (1,723), but the number dropped off rapidly
when comparing successive time-points: 315 between day 1 and day 3,
120 between day 3 and day 5, and only 31 between day 5 and day 7.
We conﬁrmed these results by clustering the list of 3,285 genes using
GeneSpring 7.3.1. The gene tree shows that, numerically, most changes
took place within the 1st day, and then began to plateau. Small subsets
of the population spiked or plummeted transiently on day one.
Conclusions: We have created a stringent database of gene expres-
sion changes during early chondrogenic differentiation of human MSCs.
Pattern analysis suggests that the bulk of the gene expression changes,
(both up- and down-regulation) occur within the ﬁrst 24 hours, with most
reﬂecting a permanent change; a much smaller subset showed transient
changes. Overall, this database will be a useful tool for interpreting the
molecular changes associated with chondrogenic differentiation of MSCs.
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Purpose: Radiography can identify knees with structural OA changes,
but it is unclear whether knees with joint space narrowing (JSN) have a
higher likelihood of subsequent cartilage loss in MRI than those without. In
an attempt to examine progression in early and more advanced disease
in the same subjects, it has been suggested that progression may be
assessed in contra-lateral knees, where one knee displays JSN and the
other one does not. We therefore examined whether knees with JSN
at baseline have a higher likelihood of subsequent cartilage loss than
contra-lateral knees with less (or without) JSN.
Methods: The subsample studied was drawn from 2678 cases from the
OA Initiative (OAI public-use datasets1.2.1 Clinical Data set and 1.B.1
Imaging Data set), a multi-center, longitudinal cohort study designed to
identify biomarkers for the development and progression of symptomatic
knee OA. Patients were selected to fulﬁll the following criteria: bilateral
frequent pain (both knees), BMI> 25, medial JSN (OARSI grade 1−3)
in one knee, but no or less medial JSN in the contra-lateral knee, and
no (or less) JSN in the lateral (than in the medial) compartment. The
knees were initially selected based on radiographic status of the site
readings in ﬁxed ﬂexion radiographs and were re-read centrally to conﬁrm
unilateral medial JSN. 80 participants met the eligibility criteria (32 men,
48 women; age = 60.6±9.1 yrs. [mean±SD]; BMI = 31.1±4.0). Of these,
73 were JSN 0 and 7 medial JSN 1 in the less affected knee, whereas
47 were medial JSN 1, 25 JSN 2, and 8 JSN 3 in the more severely
affected knee. Baseline and year 1 follow-up sagittal DESSwe MR images
of both knees (0.7mm slice thickness) were obtained on 3T Siemens
Trio scanners. 7 experienced readers segmented the medial tibial (MT)
and medial femoral condylar (MF) cartilage, with blinding to the order
of acquisition. All segmentations were quality controlled by one reader
(S.M.). The mean cartilage thickness over the entire subchondral bone
area (ThCtAB) was computed using proprietary software. The femoral
condyle was separated into a weight-bearing (cMF) and posterior part
(pMF) at 75% between the trochlear notch and the posterior end of the
femur. The mean change (MC%), SD of change, standardized response
mean (SRM=MC/SD) of ThCtAB were calculated in these regions of the
medial femorotibial compartment.
Results: Whereas knees without JSN showed relatively little progression
in all regions (0 to −1%, SRM−0.33), those with JSN (1−3) tended to
display a higher rate of change (Table 1).
Table 1: Cartilage loss in the medial femorotibial compartment as a function of JSN at baseline
MT cMF pMF
MC% SRM MC% SRM MC% SRM
Knees with less JSN (n = 80)
JSN 0 n=73 −1.0% −0.33 −1.0% −0.16 0.0% 0.0
JSN 1 n=7 −3.9% −0.36 −12% −0.40 −3.9% −0.77
Knees with more JSN (n = 80)
JSN 1 n=43 −1.6% −0.36 −0.3% −0.55 −0.7% −0.15
JSN 2 n=25 −2.9% −0.50 −7.2% −0.70 −3.2% −0.70
JSN 3 n=8 −6.9% −0.62 −12% −1.15 −4.0% −0.49
In the more severely affected knee, the rate of change and SRM increased
with worse grades of JSN (JSN 2 or 3 vs. JSN 1 = p< 0.001 for cMF and
p< 0.05 for pMF). In knees with grade 2 or 3 JSN, the change was higher
in cMF than in MT (p = 0.01) and than in pMF (p = 0.08). The highest
sensitivity to change was observed in the cMF of the JSN 3 knees (n = 8;
SRM=1.15; Table 1).
Conclusions: JSN at baseline predicts subsequent cartilage loss, as
measured by quantitative MRI. The rate and sensitivity to change in-
creased as a function of worsening JSN (1−3). This suggests that MRI-
based measures of cartilage morphometry are particularly responsive at
the later disease stages.
